|
|
 |
|
Viewing report
|
|
|
|
Drugs of Abuse Testing Markets
TriMark Publications, July 2011, Pages: 281
This report describes the specific segment of the in vitro diagnostics (IVD) market known as drugs of abuse testing. In the current medical diagnostics market, drugs of abuse testing offers promise for significant growth and innovation. Examined in this study are assays for alcohol, cannabinoids, cocaine, amphetamines, opiates and phencyclidine, as well as assays for addictive prescription drugs such as OxyContin. Moreover, special attention is paid to Substance Abuse and Mental Health Service Administration (SAMHSA) requirements, which aims to prevent substance abuse in the U.S. and so requires that certain corporations comply with anti-drug policies and testing.
This review covers the leading market players, the competitive landscape, and the promising pipeline products in the drugs of abuse testing markets. Specifically, areas examined in this study include: available and developing technologies in the field, the U.S. and global market size for drugs of abuse tests, and the profiles of companies that are focusing on the drugs of abuse testing market. Detailed charts with sales forecasts and market share data for the U.S. and global drugs of abuse testing markets are included.
|
|
|
|
